Anticonvulsant effect of fluoxetine in humans.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7477995.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report an unblinded, open-label, add-on trial of fluoxetine, a selective serotonin reuptake inhibitor, in 17 patients with complex partial seizures with and without secondary generalization (mean follow-up duration, 14 +/- 1.1 months). Six patients showed complete disappearance of their daily seizures; in the others the seizure frequency was lowered by 30%. No patient reported side effects.
Medical subject headings
- Anticonvulsants
- Epilepsy
- Fluoxetine